Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of schizophrenia in Ashkenazi Jews.
|
26198764 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Of these genes, INHBA, a TGF-β ligand found mutated in lung adenocarcinoma, showed reduced expression in BMICs with knockdown of SPOCK1.
|
28766011 |
2017 |
Eclampsia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
CpG sites from four genes relevant to pre-eclampsia (INHBA, BHLHE40, SLC2A1 and ADAM12) showed different extent of changes in LOPET and nIUGR.
|
23770704 |
2013 |
Desmoplastic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1.
|
21047417 |
2010 |
Pre-Eclampsia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Oxidative stress increases placental and endothelial cell activin A secretion.
|
17332518 |
2007 |
Fibroid Tumor
|
0.300 |
Biomarker
|
disease |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Uterine Fibroids
|
0.300 |
Biomarker
|
group |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Uterine Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Uterine Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
|
22228119 |
2012 |
Liver Failure, Acute
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activin A and follistatin in acute liver failure.
|
12560755 |
2003 |
Abdomen distended
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abdominal mass
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ascites
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysmenorrhea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Endometriosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Intestinal Obstruction
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Menorrhagia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nausea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pleural effusion disorder
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Thromboembolism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Urgency of micturition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cervical lymphadenopathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ovarian mucinous tumor
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Episodic vomiting
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|